BitcoinWorldRevolutionary Shift: How Sonnet BioTherapeutics Became a $305M Digital Asset Treasury PowerhouseIn a move that signals a seismic shift in corporate strategy, a Nasdaq-listed biotech firm has just voted to transform its entire future. Sonnet BioTherapeutics shareholders have approved a groundbreaking merger to pivot the company into a digital asset treasury firm. This isn’t just a rebrand; it’s a complete reinvention, positioning the new entity, Hyperliquid […]This post Revolutionary Shift: How Sonnet BioTherapeutics Became a $305M Digital Asset Treasury Powerhouse first appeared on BitcoinWorld.
